USPTO serial 88731463
EPIZON PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 7, 2020
- Examiner
- MARTIN, LIEF ANDREW
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EPIZON PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Woodbridge, CT, US
Woodbridge, CT, US
Orange, CT, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander P. Montgomery
Alexander P. Montgomery Hinckley, Allen & Snyder, LLP28 State Street, 30th FloorBOSTON, MA 02109United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment of vascular disease, cardiovascular disease, heart disease, osteoporosis, bone disease, renal disease, kidney disease, auto immune disease, arteriosclerosis, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reaction, anaphylaxis or asthma | ACTIVE | Jul 30, 2018 |
| 042 | development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reactions, anaphylaxis or asthma | ACTIVE | Dec 23, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Epizon Pharma, Inc.
- Other trademarks owned by Epizon Pharma, Inc.
- Other trademarks owned by Epizon Pharma, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named EPIZON PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 19, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 19, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 1, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 1, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 7, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 19, 2020 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Mar 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2020 | IUAA | USE AMENDMENT ACCEPTED | — |
| Mar 18, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 18, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 18, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 18, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2020 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Jan 23, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jan 22, 2020 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Jan 21, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 7, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 24, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 21, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 21, 2019 | NWAP | NEW APPLICATION ENTERED | — |